• 1
    Ramsdale EH, Morris MM, Roberts RS, Hargreave FE. Asymptomatic bronchial hyperresponsiveness in rhinitis. J Allergy Clin Immunol 1985;75: 573577.
  • 2
    Crimi N, Palermo F, Oliveri R, Vancheri C, Di Stefano SM, Palermo B et al. Influence of asthmatic and rhinitic symptomatology and duration on bronchial responsiveness to histamine. Int J Tissue React 1987;IX: 515520.
  • 3
    Djukanovic R, Lai CKW, Wilson JW, Britten KM, Wilson SJ, Roche WR et al. Bronchial mucosal manifestation of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic non-asthmatics and healthy controls. Eur Respir J 1992;5: 538544.
  • 4
    Foresi A, Leone C, Pelucchi A, Mastropasqua B, Chetta A, D'ippolito R et al. Eosinophils, mast cells, and basophils in induced sputum from patients with seasonal allergic rhinitis and perennial asthma: relationship to methacholine responsiveness. J Allergy Clin Immunol 1997;100: 5864.
  • 5
    Polosa R, Ciamarra I, Mangano G, Prosperini G, Pistorio MP, Vancheri C et al. Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis. Eur Respir J 2000;15: 3035.
  • 6
    Hopp RJ, Townley RG, Biven RE, Bewtra AK, Nair NM. The presence of airway reactivity before the development of asthma. Am Rev Respir Dis 1990;141: 28.
  • 7
    Braman SS, Barrows AA, DeCotiis BA, Settipane GA, Corrao WM. Airway hyperresponsiveness in allergic rhinitis: a risk factor for asthma. Chest 1987;91: 671674.
  • 8
    Greisner WA III, Settipane RJ, Settipane GA. Co-existence of asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Asthma Proc 1998;19: 185188.
  • 9
    Danielsson J, Jessen M. The natural course of allergic rhinitis during 12 years of follow-up. Allergy 1997;52: 331334.
  • 10
    Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998;102 (4 Pt 1):531542.
  • 11
    Barnes PJ. Is immunotherapy for asthma worthwhile? N Engl J Med 1996;334: 531532.
  • 12
    Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hayfever uncontrolled by antiallergic drugs. BMJ 1991;302: 265269.
  • 13
    Jacobsen L, Nuchel Petersen B, Wihl JA, Lowenstein H, Ipsen H. Immunotherapy with partially purified and standardized tree pollen extracts: IV. Results from long-term (6-year) follow-up. Allergy 1997;52: 914920.
  • 14
    Moller C, Dreborg S, Ferdousi HA, Halken S, Host A, Jacobsen L et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002;109: 251256.
  • 15
    Polosa R. Can immunotherapy prevent progression to asthma in allergic individuals? J Allergy Clin Immunol 2002;110: 672673.
  • 16
    Johnstone DE, Dutton DA. The value of hyposensitisation therapy for bronchial asthma in children: a 14-year study. Pediatrics 1968;42: 793802.
  • 17
    Grembiale RD, Camporota L, Naty S, Tranfa CM, Djukanovic R, Marsico SA. Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000;162: 20482052.
  • 18
    Polosa R, Sarva’ M, Palermo F, Lisitano N, Vancheri C, Crimi N. Immunotherapy prevents the development of asthma in subjects with allergic rhinitis. Eur Respir J 2001;18 (Suppl. 33):482s.
  • 19
    D'Amato G, Spieksma M, Liccardi G, Jäger S, Russo M, Kontou-Fili K et al. Pollen-related allergy in Europe. Allergy 1998;53: 567578.
  • 20
    Polosa R, Li Gotti F, Mangano G, Mastruzzo C, Pistorio MP, Crimi N. Monitoring of seasonal variability in bronchial hyper-responsiveness and sputum cell counts in non-asthmatic subjects with rhinitis and effect of specific immunotherapy. Clin Exp Allergy 2003;33: 873881.
  • 21
    D'Amato G, Liccardi G, Russo M, Saggese M, D'Amato M. Measurement of serum levels of eosinophil cationic protein to monitor patients with seasonal respiratory allergy induced by Parietaria pollen (treated and untreated with specific immunotherapy). Allergy 1996;51: 245250.
  • 22
    Pichler CE, Helbling A, Pichler WJ. Three years of specific immunotherapy with house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity. Allergy 2001;56: 301306.
  • 23
    Walker SM, Pajno G, Torres-Lima M, Wilson DR, Durham SR. Grass pollen immunotherapy in seasonal rhinitis and asthma: a randomized controlled trial. J Allergy Clin Immunol 2001;107: 8793.
  • 24
    Rak S, Bjornson A, Hakanson L, Sorenson S, Venge P. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 1991;88: 878888.